Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R.L. Kaufman, R.C. Kitridou.
Pregnancy in mixed connective tissue disease: comparison with systemic lupus erythematosus.
J Rheumatol, 9 (1982), pp. 549-555
[2.]
L.B. Donaldson, R.R. Álvarez.
Further observations on lupus erythematosus associated with pregnancy.
Am J Obstet Gynecol, 83 (1962), pp. 1461-1463
[3.]
M. Petri.
Systemic lupus erythematosus and pregnancy.
Rheum Dis Clin North Am, 20 (1997), pp. 87-118
[4.]
R. Cervera, J. Font, F. Carmona, J. Balasch.
Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium.
Autoimmun Rev, 1 (2002), pp. 354-359
[5.]
A.P. Weetman.
The immunology of pregnancy.
Thyroid, 9 (1999), pp. 643-646
[6.]
A. Moffett, Y.W. Loke.
The immunological paradox of pregnancy: a reappraisal.
Placenta, 25 (2004), pp. 1-8
[7.]
S. Saito.
Cytokine network at the maternal-fetal interface.
J Reprod Immunol, 47 (2000), pp. 87-103
[8.]
R. Bulla, F. Fischetti, F. Bossi, F. Tedesco.
Feto-maternal immune interaction at the placental level.
Lupus, 13 (2004), pp. 625-629
[9.]
M. Petri.
Systemic lupus erythematosus and pregnancy.
Rheum Dis Clin North Am, 20 (1994), pp. 87-119
[10.]
M.D. Lockshin, E. Reinitz, M.L. Druzin, et al.
Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy.
Am J Med, 77 (1984), pp. 893-898
[11.]
G. Mintz, J. Niz, G. Gutiérrez, et al.
Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach.
J Rheumatol, 13 (1986), pp. 732-739
[12.]
M.B. Urowitz, D.D. Gladman, V.T. Farewell, et al.
Lupus and pregnancy studies.
Arthritis Rheum, 36 (1993), pp. 1392-1397
[13.]
K.L. Wong, F.Y. Chan, C.P. Lee.
Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study.
Arch Intern Med, 151 (1991), pp. 269-273
[14.]
M. Petri, D. Howard, J. Repke.
Frequency of lupus flares in pregnancy. The Hopkins Lupus Pregnancy Center experience.
Arthritis Rheum, 151 (1991), pp. 269-273
[15.]
G. Ruiz-Irastorza, F. Lima, J. Alves, et al.
Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies.
J Rheumatol, 35 (1996), pp. 133-138
[16.]
J.P. Buyon, K.C. Kalunian, R. Ramsey-Goldman, et al.
Assessing disease activity in SLE patients during pregnancy.
Lupus, 8 (1999), pp. 677-684
[17.]
M.A. Saavedra, S.M. Carrillo, D.X. Xibille, J.M. Miranda, M. Cisneros, L.J. Jara.
Comparative analysis of six systemic lupus erythematosus indexes during pregnancy.
Arthritis Rheum, 46 (2002), pp. 323
[18.]
G. Ruiz-Irastorza, M.A. Khamashta, C. Gordon, et al.
Measuring systemic lupus erythematosus activity during pregnancy: validation of the Lupus Activity Index in Pregnancy scale.
Arthritis Rheum, 51 (2004), pp. 78-82
[19.]
H.C. Nossent, T.J. Swaak.
Systemic lupus erythematosus VI. Analysis of the interrelationship with pregnancy.
J Rheumatol, 17 (1990), pp. 771-776
[20.]
M. Khamashta, G. Ruiz-Irastorza, G.R.V. Hughes.
Systemic lupus erythematosus flares during pregnancy.
Rheum Dis Clin North Am, 23 (1997), pp. 15-30
[21.]
J.I. Zulman, N. Talal, G. Hoffman, W.V. Epstein.
Problems associated with the management of pregnancies in patients with systemic lupus erythematosus.
J Rheumatol, 7 (1980), pp. 37-49
[22.]
M.T. Houser, A.J. Fish, G.E. Tagatz, et al.
Pregnancy and systemic lupus erythematosus.
Am J Obstet Gynecol, 138 (1980), pp. 409-413
[23.]
J.P. Hayslett, R.I. Lynn.
Effect of pregnancy in patients with lupus nephropathy.
Kidney Int, 18 (1980), pp. 207-220
[24.]
P. Jungers, M. Dougados, C. Pelissier, et al.
Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients.
Arch Intern Med, 142 (1982), pp. 771-776
[25.]
G. Bobrie, F. Liote, P. Houillier, et al.
Pregnancy in lupus nephritis and related disorders.
Am J Kidney Dis, 9 (1987), pp. 339-343
[26.]
J. Cortés-Hernández, J. Ordi-Ros, F. Paredes, et al.
Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies.
Rheumatology (Oxford), 41 (2002), pp. 643-650
[27.]
G. Moroni, S. Quaglini, G. Banfi, et al.
Pregnancy in lupus nephritis.
Am J Kidney Dis, 40 (2002), pp. 713-720
[28.]
D. Lê Thi Houng, B. Wechsler, D. Vauthier-Brouzes, et al.
Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study of 62 pregnancies.
Br J Rheumatol, 36 (1997), pp. 772-777
[29.]
G. Ruiz-Irastorza, M.A. Khamashta, G.R.V. Hughes.
Systemic lupus erythematosus and antiphospholipid syndrome during pregnancy: Maternal and fetal complications and their management.
IMAJ, 2 (2000), pp. 462-469
[30.]
N.M.M. Buchanan, E. Toubi, M.A. Khamashta, F. Lima, S. Kerslake, G.R.V. Hughes.
Hydroxychloroquine and lupus pregnancy: a review of a series of 36 cases.
Ann Rheum Dis, 55 (1996), pp. 486-488
[31.]
N. Costedoat-Chalumeau, Z. Amoura, P. Duhaut, et al.
Safety of hidroxychloroquine in pregnant patients with connective tissue diseases.
Arthritis Rheum, 48 (2003), pp. 3207-3211
[32.]
R.A. Levy, V.S. Vilela, M.J. Cataldo, et al.
Hydroxychloroquine in lupus pregnancy: double-blind and placebo-controlled study.
Lupus, 10 (2001), pp. 401-404
[34.]
M. Østensen, H. Østensen.
Safety of non-steroidal anti-inflammatory drugs in pregnancy patients with rheumatic diseases.
J Rheumatol, 23 (1996), pp. 1045-1049
[35.]
N.M. Janssen, M. Genta.
The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy and lactation.
Arch Intern Med, 160 (2000), pp. 610-619
[36.]
M. Østensen.
Disease specific problems related to drug therapy in pregnancy.
Lupus, 13 (2004), pp. 746-750
[37.]
B. Bermas, J. Hill.
Effects of immunosuppressive drugs during pregnancy.
Arthritis Rheum, 38 (1995), pp. 1722-1732
[38.]
M.J. Johnson.
Obstetric complications and rheumatic disease.
Rheum Dis Clin North Am, 23 (1997), pp. 169-182
[39.]
D.W. Branch, R. Andres, K. Digre, N.S. Rote, J.R. Scott.
The association of antiphospholipid antibodies with severe preeclampsia.
Obstet Gynecol, 73 (1989), pp. 541-545
[40.]
G.A. Dekker, J.I. De Vries, P.M. Doelitzsch, et al.
Underlying disorders associated with severe early-onset preeclampsia.
Am J Obstet Gynecol, 173 (1995), pp. 1042-1048
[41.]
D. Lê Thi Thoung, N. Tieulié, N. Costedoat, et al.
The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women.
Ann Rhem Dis, 64 (2005), pp. 273-278
[42.]
E. Oviasu, J. Hicks, J.S. Cameron.
The outcome of pregnancy in women with lupus nephritis.
Lupus, 1 (1991), pp. 19-25
[44.]
H. Julkunen, R. Kaaja, T. Palosuo, et al.
Pregnancy in lupus nephropathy.
Acta Obstet Gynecol Scand, 72 (1993), pp. 258-263
[45.]
F. Carmona, J. Font, R. Cervera, et al.
Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases.
Eur J Obstet Gynecol Reprod Biol, 83 (1999), pp. 137-142
[46.]
D. Lê Thi Houng, B. Wechsler, D. Vauthier-Brouzes, et al.
Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single center.
Ann Rheum Dis, 60 (2001), pp. 599-604
[47.]
A. Tandon, D. Ibáñez, D.D. Gladman, M.B. Urowitz.
The effect of pregnancy on lupus nephritis.
Arthritis Rheum, 50 (2004), pp. 3941-3946
[48.]
J.T. Repke.
Hypertensive disorders of pregnancy. Differentiating preeclampsia from active systemic lupus erythematosus.
J Reprod Med, 43 (1998), pp. 350-354
[49.]
A.K. Singh.
Lupus nephritis and the antiphospholipid syndrome in pregnancy.
Kidney Int, 58 (2000), pp. 2240-2254
[50.]
H. Minakami, S. Idei, T. Koike, T. Tamada, Y. Yasuda, N. Hirota.
Active lupus and preeclampsia: a life threatening combination.
J Rheumatol, 21 (1994), pp. 1562-1563
[51.]
J.P. Buyon, B.N. Cronstein, M. Morris, et al.
Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia.
Am J Med, 21 (1986), pp. 194-200
[52.]
J. Buyon, J. Tamerius, S. Ondorica, B. Young, S.B. Abramson.
Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancies.
Arthritis Rheum, 35 (1993), pp. 55-61
[53.]
T.T. Lao, B.F.H. Leung.
Serum urate, complement 3 and pre-eclampsia in patients with systemic lupus erythematosus.
Eur J Obstet Gynecol Reprod Biol, 29 (1988), pp. 7-13
[54.]
P. Rahman, D.D. Gladman, M.B. Urowitz.
Clinical predictors of fetal outcome in systemic lupus erythematosus.
J Rheumatol, 25 (1998), pp. 1526-1530
[55.]
M.L. Gimovsky, M. Montoso, R.H. Paul.
Pregnancy outcome in women with systemic lupus erythematosus.
Obstet Gynecol, 63 (1984), pp. 686-692
[56.]
P.E. Georgiou, E.N. Politi, P. Katsimbri, V. Saca, A.A. Drosos.
Outcome of lupus pregnancy: a controlled study.
Rheumatology (Oxford), 39 (2000), pp. 1014-1019
[57.]
M.E.B. Clowse, L.S. Magder, F. Witter, M. Petri.
The impact of increased lupus activity on obstetric outcomes.
Arthritis Rheum, 52 (2005), pp. 514-521
[58.]
R. Ramsey-Goldman, J.E. Kutzer, L.H. Kuller, et al.
Previous pregnancy outcome is an important determinant to subsequent pregnancy outcome in women with systemic lupus erythematosus.
Am J Reprod Immunol, 28 (1992), pp. 195-198
[59.]
J.O. Martínez-Rueda, C.A. Arce-Salinas, A. Graus, et al.
Factors associated with fetal losses in severe systemic lupus erythematosus.
Lupus, 5 (1996), pp. 113-119
[61.]
J.S. Ginsberg, P. Brill-Edwards, M. Johnston, et al.
Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus eryhematosus: a cross-sectional study.
Blood, 80 (1992), pp. 975-980
[62.]
M.D. Lockshin, M.L. Druzin, S. Goei, et al.
Antibody to cardiolipin as a predictor of fetal distress of death in pregnant patients with systemic lupus erythematosus.
N Engl J Med, 313 (1985), pp. 152-156
[63.]
W.H. Kutteh, E.C. Lyda, S.M. Abraham, M.C. Wacholtz.
Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus.
Fertil Steril, 60 (1993), pp. 449-455
[64.]
E. Imbasciati, M. Surian, S. Bottino, et al.
Lupus nephropathy and pregnancy. A study of 26 pregnancies in patients with systemic lupus erythematosus and nephritis.
Nephron, 36 (1984), pp. 46-51
[65.]
M. Petri, J. Allbritton.
Foetal outcomes in lupus pregnancy: a retrospective case control study of the Hopkins Lupus Cohort.
J Rheumatol, 20 (1993), pp. 650-656
[66.]
D.T. Lê Thi Houng, B. Wechsler, J.C. Piette, O. Bletry, P. Godeau.
Pregnancy and its outcomes in SLE.
QJM, 87 (1994), pp. 721-729
[67.]
M.J. Johnson, M. Petri, F.R. Witter, J.T. Repke.
Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic.
Obstet Gynecol, 86 (1995), pp. 396-399
[68.]
N. Kobayashi, H. Yamada, T. Kishiida, et al.
Hypocomplementaemia correlates with intrauterine growth retardation in systemic lupus erythematosus.
Am J Reprod Immunol, 28 (1992), pp. 205-207
[69.]
J. Balasch, R. Cervera.
Reflections on the management of reproductive failure in the antiphospholipid syndrome– the clinician's perspective.
Lupus, 11 (2002), pp. 467-477
[70.]
R.H.W. Derksen, M.A. Khamashta, D.W. Branch.
Management of the obstetric antiphospholipid syndrome.
Artritis Rheum, 50 (2004), pp. 1028-1039
[71.]
M.D. Lockshin, M.L. Druzin, T. Qamar.
Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody.
Am J Obstet Gynecol, 160 (1989), pp. 439-443
[72.]
D.W. Branch, R.M. Silver, J.L. Blackwell, J.C. Reading, J.R. Scott.
Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.
Obstet Gynecol, 80 (1992), pp. 614-620
[73.]
M.H. Rosove, K. Tabsh, N. Wasserstrum, P. Howard, B.H. Hahn, K.C. Kalunian.
Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies.
Obstet Gynecol, 75 (1990), pp. 630-634
[74.]
D.W. Branch, A.M. Peaceman, M. Druzin, et al.
A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy.
Am J Obstet Gynecol, 182 (2000), pp. 122-127
[75.]
C.C. Mok, R.W.S. Wong.
Pregnancy in systemic lupus erythematosus.
Postgrad Med J, 77 (2001), pp. 157-165
[76.]
B.J. Sanson, A.W.A. Lensing, M.H. Prins, et al.
Safety of low-molecular-weight heparin in pregnancy: a systematic review.
Thromb Haemost, 81 (1999), pp. 668-672
[77.]
Committee on drugs, American Academy of Pediatrics.
The transfer of drugs and other chemicals into human milk.
Pediatrics, 93 (1994), pp. 137-150
[78.]
W.F. Rayburn.
Connective tissue disorders and pregnancy. Recommendations for prescribing.
J Reprod Med, 43 (1998), pp. 341-349
[79.]
J.P. Specer, L.S. González, D.J. Barnhart.
Medications in the breast-feeding mother.
Am Fam Phys, 64 (2001), pp. 119-126.80
[80.]
S. Ito.
Drug therapy for breast-feeding women.
N Engl J Med, 343 (2000), pp. 118-126
[81.]
R. Watson, A.T. Lane, N.K. Barnett, et al.
Neonatal lupus erythematosus. A clinical and immunogenetic study with review of the literature.
Medicine (Baltimore), 63 (1984), pp. 362-378
[83.]
A. Brucato, J.P. Buyon, A.C. Horsfall, L.A. Lee, M. Reichlin.
Fourth international workshop on neonatal lupus syndromes and the Ro/SSA-La/SSB system.
Clin Exp Rheumatol, 17 (1999), pp. 30-36
[84.]
C.E. Tseng, J.P. Buyon.
Neonatal lupus syndromes.
Rheum Dis Clin North Am, 23 (1997), pp. 31-54
[86.]
J.P. Buyon, R.M. Clancy.
Maternal autoantibodies and congenital heart block: mediators, markers and therapeutic approach.
Semin Arthritis Rheum, 33 (2003), pp. 140-154
[87.]
R.M. Clancy, J.P. Buyon.
More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block.
Rheum Dis Clin North Am, 30 (2004), pp. 589-602
[88.]
R. Ramsey-Goldman, D. Hom, J.S. Deng, G.C. Ziegler, L.E. Kahl, V.D. Oteen, et al.
Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus.
Arthritis Rheum, 29 (1986), pp. 1269-1273
[89.]
A.B. McCune, W.L. Weston, L.A. Lee.
Maternal and fetal outcome in neonatal lupus erythematosus.
Ann Intern Med, 106 (1987), pp. 518-523
[90.]
A.M.M. Groves, L.D. Allan, E. Rosenthal.
Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus.
Circulation, 92 (1995), pp. 3394-3396
[91.]
J.M.P.J. Brear, G.H.A. Visser, A.A. Kruize, P. Stoutenbeek, E.J. Meijboom.
Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature.
Ultrasound Obstet Gynecol, 24 (2004), pp. 467-472
[92.]
L.G. Rider, J.P. Buyon, J. Rutledge, D.D. Sherry.
Treatment of neonatal lupus: case report and review of the literature.
J Rheumatol, 20 (1993), pp. 1208-1211
[93.]
S. Salleb, J. Copel, D. Friedman, J.P. Buyon.
Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block.
Arthritis Rheum, 42 (1999), pp. 2335-2345
Copyright © 2005. Elsevier España S.L. Barcelona
